BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Elcelyx Therapeutics 



San Diego  California    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Elcelyx Therapeutics Announces Positive Results in Phase 2b Study of NewMet in Type 2 Diabetes 10/21/2013 8:48:10 AM    More...
Elcelyx Therapeutics to Present Clinical Data on NewMet in Type 2 Diabetes at the 49th Annual European Association for the Study of Diabetes Meeting 9/17/2013 9:27:39 AM    More...
Elcelyx Therapeutics' NewMet for Type 2 Diabetes Meets Primary Endpoint in Phase 2b Study 9/4/2013 9:57:19 AM    More...
NaZura BioHealth Spun-Out From Elcelyx Therapeutics to Advance Lovidia for Weight Management 9/4/2013 6:56:09 AM    More...
Elcelyx Therapeutics' Study Shows NewMet Has Better Glucose-Lowering Effects Than Metformin 6/24/2013 6:49:27 AM    More...
Elcelyx Therapeutics to Present Clinical Data on NewMet™ in Type 2 Diabetes at the 2013 American Diabetes Association Scientific Sessions 6/17/2013 8:43:24 AM    More...
Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 5/20/2013 1:52:58 PM    More...
Elcelyx Therapeutics Closes on $20 Million to Advance Appetite-Control Compounds 2/14/2013 6:58:03 AM    More...
Elcelyx Therapeutics Names Mark Wiggins Senior Vice President of Business Development, Ginger Graham to Board of Directors 8/13/2012 9:56:29 AM    More...
Elcelyx Therapeutics Raises $4 Million 8/13/2012 7:45:21 AM    More...
12

//-->